Penobscot Investment Management Company, Inc.
Source: SEC Form 13F · as of Mar 2026Penobscot Investment Management Company, Inc. holds 20 biotech & pharma companies tracked by BioSniper, totaling $82.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$82.3M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 76,399 | $16.6M |
| JNJJOHNSON & JOHNSON | 56,524 | $13.8M |
| LLYELI LILLY & Co | 12,057 | $11.1M |
| AZNASTRAZENECA PLC | 50,083 | $9.9M |
| AMGNAMGEN INC | 16,956 | $6.0M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 20,962 | $5.7M |
| ABTABBOTT LABORATORIES | 43,107 | $4.4M |
| NVSNovartis AG | 28,286 | $4.3M |
| MRKMerck & Co., Inc. | 31,407 | $3.8M |
| PFEPFIZER INC | 79,412 | $2.2M |
| BMYBRISTOL MYERS SQUIBB CO | 13,778 | $836K |
| NVONovo Nordisk A/S | 19,540 | $718K |
| PMPhilip Morris International Inc | 3,348 | $554K |
| MCKMcKesson Corporation | 555 | $480K |
| GILDGILEAD SCIENCES, INC. | 2,848 | $397K |
| IDXXIDEXX LABORATORIES INC /DE | 705 | $396K |
| WSTWest Pharmaceutical Services Inc. | 1,450 | $363K |
| ZTSZoetis Inc. | 2,340 | $277K |
| UTMDUtah Medical Products Inc. | 4,000 | $248K |
| REGNREGENERON PHARMACEUTICALS, INC. | 320 | $247K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.